Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birkett

Showing results (911-920 of 940) with videos related to

Pageof 94
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2018
<i>Plasmodium</i>-associated changes in human odor attract mosquitoesAilie Robinson, Annette O Busula, Mirjam A Voets, et al.
Plos One|September 1, 2012
Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriersTeun Bousema, Rhoel R Dinglasan, Isabelle Morlais, et al.
NPJ Vaccines|July 3, 2026
Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite proteinMohammad Naghizadeh, Yevel Flores-Garcia, Reem Moskovitz, et al.
The Lancet. Infectious Diseases|August 13, 2022
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adultsSaskia C van der Boor, Merel J Smit, Stijn W van Beek, et al.
Plos Neglected Tropical Diseases|February 27, 2016
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and EfficacyJason W Bennett, Anjali Yadava, Donna Tosh, et al.
NPJ Vaccines|October 11, 2018
Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trialKavita Singh, Paushali Mukherjee, Ahmad Rushdi Shakri, et al.
British Journal of Cancer|December 31, 2021
The multi-specific V<sub>H</sub>-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activityCarolyn J Edwards, Angelica Sette, Carl Cox, et al.
Human Genetics|February 3, 2009
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE StatementJulian Little, Julian P T Higgins, John P A Ioannidis, et al.
Plos Medicine|February 6, 2009
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statementJulian Little, Julian P T Higgins, John P A Ioannidis, et al.
Journal of Clinical Epidemiology|February 17, 2009
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statementJulian Little, Julian P T Higgins, John P A Ioannidis, et al.
Pageof 94

Showing results (911-920 of 940) with videos related to

Sort By:
Pageof 94
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2018
<i>Plasmodium</i>-associated changes in human odor attract mosquitoesAilie Robinson, Annette O Busula, Mirjam A Voets, et al.
Plos One|September 1, 2012
Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriersTeun Bousema, Rhoel R Dinglasan, Isabelle Morlais, et al.
NPJ Vaccines|July 3, 2026
Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite proteinMohammad Naghizadeh, Yevel Flores-Garcia, Reem Moskovitz, et al.
The Lancet. Infectious Diseases|August 13, 2022
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adultsSaskia C van der Boor, Merel J Smit, Stijn W van Beek, et al.
Plos Neglected Tropical Diseases|February 27, 2016
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and EfficacyJason W Bennett, Anjali Yadava, Donna Tosh, et al.
NPJ Vaccines|October 11, 2018
Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trialKavita Singh, Paushali Mukherjee, Ahmad Rushdi Shakri, et al.
British Journal of Cancer|December 31, 2021
The multi-specific V<sub>H</sub>-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activityCarolyn J Edwards, Angelica Sette, Carl Cox, et al.
Human Genetics|February 3, 2009
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE StatementJulian Little, Julian P T Higgins, John P A Ioannidis, et al.
Plos Medicine|February 6, 2009
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statementJulian Little, Julian P T Higgins, John P A Ioannidis, et al.
Journal of Clinical Epidemiology|February 17, 2009
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statementJulian Little, Julian P T Higgins, John P A Ioannidis, et al.
Pageof 94